Regeneron Pharmaceuticals (REGN) Net Cash Flow Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.46% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -125.22% |
| Dec 31, 2025 | 27.83% |
| Sep 30, 2025 | 501.33% |
| Jun 30, 2025 | -58.20% |
| Mar 31, 2025 | 573.25% |
| Dec 31, 2024 | -17.23% |
| Sep 30, 2024 | -60.70% |
| Jun 30, 2024 | 65.57% |
| Mar 31, 2024 | -115.75% |
| Dec 31, 2023 | 249.82% |
| Sep 30, 2023 | 119.02% |
| Jun 30, 2023 | -4,105.47% |
| Mar 31, 2023 | 75.54% |
| Dec 31, 2022 | 29.52% |
| Sep 30, 2022 | -92.93% |
| Jun 30, 2022 | -92.21% |
| Mar 31, 2022 | 160.92% |
| Dec 31, 2021 | -188.09% |
| Sep 30, 2021 | 425.33% |
| Jun 30, 2021 | 393.66% |
| Mar 31, 2021 | -228.20% |
| Dec 31, 2020 | 166.39% |
| Sep 30, 2020 | -223.22% |
| Jun 30, 2020 | 67.42% |
| Mar 31, 2020 | 145.18% |
| Dec 31, 2019 | -38.67% |
| Sep 30, 2019 | 99.71% |
| Jun 30, 2019 | -552.56% |
| Mar 31, 2019 | 16.44% |
| Dec 31, 2018 | 1,740.78% |
| Sep 30, 2018 | 255.80% |
| Jun 30, 2018 | -50.61% |
| Mar 31, 2018 | -25.23% |
| Dec 31, 2017 | 105.54% |
| Sep 30, 2017 | -82.56% |
| Jun 30, 2017 | -259.50% |
| Mar 31, 2017 | 234.99% |
| Dec 31, 2016 | -341.18% |
| Sep 30, 2016 | 3.72% |
| Jun 30, 2016 | 136.04% |
| Mar 31, 2016 | -45.50% |
| Dec 31, 2015 | 7,036.95% |
| Sep 30, 2015 | 468.80% |
| Jun 30, 2015 | -184.87% |
| Mar 31, 2015 | -90.93% |
| Dec 31, 2014 | -99.21% |
| Sep 30, 2014 | 139.18% |
| Jun 30, 2014 | -31.31% |
| Mar 31, 2014 | -47.75% |
| Dec 31, 2013 | 144.79% |
| Sep 30, 2013 | -123.75% |
| Jun 30, 2013 | 190.42% |
| Mar 31, 2013 | 43.93% |
| Dec 31, 2012 | -59.86% |
| Sep 30, 2012 | -10.49% |
| Jun 30, 2012 | -287.19% |
| Mar 31, 2012 | -490.39% |
| Dec 31, 2011 | 230.32% |
| Sep 30, 2011 | -122.47% |
| Jun 30, 2011 | 2,339.43% |
| Mar 31, 2011 | 125.40% |
| Dec 31, 2010 | -391.87% |
| Sep 30, 2010 | 1,108.68% |